Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine

被引:223
作者
Imai, Teruko
Taketani, Megumi
Shii, Mayumi
Hosokawa, Masakiyo
Chiba, Kan
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Chiba Inst Sci, Fac Pharmaceut Sci, Chiba, Japan
[3] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan
关键词
D O I
10.1124/dmd.106.009381
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2. Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2. hCE-2 has a limited ability to hydrolyze large acyl compound substrates. Interestingly, propranolol derivatives, good substrates for hCE-2, were easily hydrolyzed by substitution of the methyl group on the 2-position of the acyl moiety, but were barely hydrolyzed when the methyl group was substituted on the 3-position. These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site. In contrast, hCE-1 could hydrolyze a variety of substrates. The hydrolytic activity of hCE-2 increased with increasing alcohol chain length in benzoic acid derivative substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alcohol chains. Kinetic data showed that the determining factor for the rate of hydrolysis of p-aminobenzoic acid esters was V-max for hCE-1 and Km for hCE-2. Furthermore, the addition of hydrophobic alcohols to the reaction mixture with p-aminobenzoic acid propyl ester induced high and low levels of transesterification by hCE-1 and hCE-2, respectively. When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addition to the binding structure of the substrate in the active site of the enzyme.
引用
收藏
页码:1734 / 1741
页数:8
相关论文
共 31 条
[1]   Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist [J].
Beaumont, K ;
Webster, R ;
Gardner, I ;
Dack, K .
CURRENT DRUG METABOLISM, 2003, 4 (06) :461-485
[2]   PURIFICATION, CLONING, AND EXPRESSION OF A HUMAN ENZYME WITH ACYL-COENZYME-A - CHOLESTEROL ACYLTRANSFERASE ACTIVITY, WHICH IS IDENTICAL TO LIVER CARBOXYLESTERASE [J].
BECKER, A ;
BOTTCHER, A ;
LACKNER, KJ ;
FEHRINGER, P ;
NOTKA, F ;
ASLANIDIS, C ;
SCHMITZ, G .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08) :1346-1355
[3]   Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme [J].
Bencharit, S ;
Morton, CL ;
Xue, Y ;
Potter, PM ;
Redinbo, MR .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (05) :349-356
[4]   Structural insights into CPT-11 activation by mammalian carboxylesterases [J].
Bencharit, S ;
Morton, CL ;
Howard-Williams, EL ;
Danks, MK ;
Potter, PM ;
Redinbo, MR .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (05) :337-342
[5]   Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition [J].
Bencharit, S ;
Morton, CL ;
Hyatt, JL ;
Kuhn, P ;
Danks, MK ;
Potter, PM ;
Redinbo, MR .
CHEMISTRY & BIOLOGY, 2003, 10 (04) :341-349
[6]  
Bodor Nicholas, 2002, Methods Mol Biol, V186, P301
[7]   Lessons from a bacterial cocaine esterase [J].
Bosron, WF ;
Hurley, TD .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :4-5
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   SELECTIVE-INHIBITION OF RAT-LIVER CARBOXYLESTERASES BY VARIOUS ORGANO-PHOSPHORUS DIESTERS INVIVO AND INVITRO [J].
BRANDT, E ;
HEYMANN, E ;
MENTLEIN, R .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (13) :1927-1931
[10]  
Brzezinski MR, 1997, DRUG METAB DISPOS, V25, P1089